There have been 50 recent insider transactions recorded for Senti Biosciences, Inc. (SNTI), including 30 buys and 12 sells. Total insider buying was valued at $10.99M and total insider selling at $24.49K.
Notable insiders with recent activity include Rajangam Kanya, Lu Timothy K, Baum Bryan Daniel. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SNTI
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-09 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
Tax Withholding of RSU |
10,757 |
- |
- |
74,843 |
| 2026-03-09 |
Lu Timothy K |
CEO |
Tax Withholding of RSU |
80,666 |
- |
- |
639,583 |
| 2026-02-02 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
Tax Withholding of RSU |
1,384 |
- |
- |
85,600 |
| 2026-02-02 |
Lu Timothy K |
CEO |
Tax Withholding of RSU |
4,191 |
- |
- |
720,249 |
| 2025-07-18 |
Baum Bryan Daniel |
Director |
Unknown |
- |
- |
- |
- |
| 2025-07-18 |
Baum Bryan Daniel |
Director |
RSU Award |
43,900 |
$1.95 |
$85.61K |
43,900 |
| 2025-06-25 |
Mathers Edward T |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-06-25 |
Collins James J. |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-06-25 |
Tang Donald F |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-06-25 |
Cooperstone Brenda |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-06-25 |
Schulz Fran |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-06-25 |
Hsiung Feng |
Director |
RSU Award |
21,950 |
$2.05 |
$45K |
21,950 |
| 2025-03-10 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
Conversion (Sell) |
33 |
$2.25 |
$74.25 |
- |
| 2025-03-10 |
Bayer Healthcare Llc |
10 Percent Owner |
Conversion (Sell) |
2,222 |
- |
- |
- |
| 2025-03-10 |
New Enterprise Associates 15, L.p. |
10 Percent Owner |
Conversion (Sell) |
3,333 |
- |
- |
- |
| 2025-03-10 |
Celadon Partners Spv 24 |
10 Percent Owner |
Conversion (Sell) |
9,777 |
- |
- |
- |
| 2025-03-07 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
RSU Award |
78,363 |
- |
- |
86,984 |
| 2025-03-07 |
Lu Timothy K |
CEO and Interim Pfo and Pao |
RSU Award |
642,358 |
- |
- |
724,440 |
| 2025-03-07 |
Mathers Edward T |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-07 |
Collins James J. |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-07 |
Cross John Harry Iii |
Chief Financial Officer |
RSU Award |
174,200 |
$3.52 |
$613.18K |
174,200 |
| 2025-03-07 |
Tang Donald F |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-07 |
Cooperstone Brenda |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-07 |
Schulz Fran |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-07 |
Hsiung Feng |
Director |
Unknown |
- |
- |
- |
- |
| 2025-03-07 |
Hsiung Feng |
Director |
RSU Award |
43,900 |
$3.52 |
$154.53K |
43,900 |
| 2025-03-06 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
RSU Award |
235,088 |
$3.97 |
$933.3K |
235,088 |
| 2025-03-06 |
Lu Timothy K |
CEO and Interim Pfo and Pao |
RSU Award |
1,927,073 |
$3.97 |
$7.65M |
1,927,073 |
| 2025-03-06 |
New Enterprise Associates 15, L.p. |
10 Percent Owner |
Unknown |
13,711 |
- |
- |
- |
| 2025-03-06 |
Celadon Partners Spv 24 |
10 Percent Owner |
Unknown |
6,666,000 |
$2.30 |
$15.33M |
- |
| 2025-03-03 |
Cross John Harry Iii |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-02-06 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
Informative Sell |
182 |
$4.37 |
$795.34 |
8,621 |
| 2025-02-06 |
Lu Timothy K |
CEO |
Informative Sell |
545 |
$4.36 |
$2.38K |
82,082 |
| 2025-02-04 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
Informative Sell |
1,297 |
$4.07 |
$5.28K |
8,803 |
| 2025-02-04 |
Lu Timothy K |
CEO |
Informative Sell |
3,922 |
$4.07 |
$15.96K |
82,627 |
| 2024-12-09 |
Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. |
RSU Award |
33 |
$2.25 |
$74.25 |
33 |
| 2024-12-09 |
Tang Donald F |
Director |
Unknown |
- |
- |
- |
10,368 |
| 2024-12-09 |
Tang Donald F |
Director |
RSU Award |
12,500 |
$6.52 |
$81.5K |
12,500 |
| 2024-12-09 |
Schulz Fran |
Director |
Unknown |
- |
- |
- |
- |
| 2024-12-09 |
Schulz Fran |
Director |
RSU Award |
12,500 |
$6.52 |
$81.5K |
12,500 |
| 2024-12-09 |
Bayer Healthcare Llc |
10 Percent Owner |
Informative Buy |
2,222 |
- |
- |
2,222 |
| 2024-07-10 |
Mathers Edward T |
Director |
RSU Award |
62,500 |
$0.31 |
$19.38K |
62,500 |
| 2024-07-10 |
Farokhzad Omid |
Director |
RSU Award |
62,500 |
$0.31 |
$19.38K |
62,500 |
| 2024-07-10 |
Collins James J. |
Director |
RSU Award |
62,500 |
$0.31 |
$19.38K |
62,500 |
| 2024-07-10 |
Cooperstone Brenda |
Director |
RSU Award |
62,500 |
$0.31 |
$19.38K |
62,500 |
| 2024-05-04 |
Li Yvonne |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-02-01 |
Rajangam Kanya |
Chief Medical & Devt. Officer |
RSU Award |
101,000 |
- |
- |
101,000 |
| 2024-02-01 |
Lu Timothy K |
CEO and President |
RSU Award |
459,000 |
$0.46 |
$211.14K |
459,000 |
| 2024-02-01 |
Knobelman Deborah |
Officer, Other: Chief Financial Officer |
RSU Award |
101,000 |
- |
- |
131,000 |
| 2023-06-16 |
Berland Susan D |
Director |
RSU Award |
62,500 |
$0.99 |
$61.88K |
62,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
